M Namer
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 23
- Cancer Treatment and Pharmacology 14
- Colorectal Cancer Treatments and Studies 5
- Neutropenia and Cancer Infections 4
- HER2/EGFR in Cancer Research 3
-
- Breast Cancer Treatment Studies 7
- Co-authors
- G. MilanoMarc FrénayN. RenéeM. FrénayP. RománJean-Michel DerlonB. GirouxJacques Bonneterre
In The Last Decade
M Namer
33 papers receiving 423 citations
Peers
Comparison fields: 5 of 69
- Oncology 271
- Cancer Research 84
- Genetics 50
- Pulmonary and Respiratory Medicine 116
- Dermatology 31
Countries citing papers authored by M Namer
This map shows the geographic impact of M Namer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Namer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Namer more than expected).
Fields of papers citing papers by M Namer
This network shows the impact of papers produced by M Namer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Namer. The network helps show where M Namer may publish in the future.
Co-authors
The 25 scholars most cited alongside M Namer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 1 | |
| 2 | 2005 | 7 | |
| 3 | 2004 | 1 | |
| 4 | 2003 | 1 | |
| 5 | 2003 | 40 | |
| 6 | 2003 | 2 | |
| 7 | 2001 | 21 | |
| 8 | 2000 | 16 | |
| 9 | [Atypical presentation of carcinomatous meningitis in neuroendocrine tumor of the cervix uteri]. | 2000 | 4 |
| 10 | 1999 | 47 | |
| 11 | 1996 | 30 | |
| 12 | [Study of mdm2 gene amplification in primary breast tumors]. | 1994 | 10 |
| 13 | 1991 | 12 | |
| 14 | 1991 | 46 | |
| 15 | 1991 | 11 | |
| 16 | 1991 | 12 | |
| 17 | [Evaluation of the "squamous cell carcinoma antigen" as marker of epidermoid cancer of the anal canal]. | 1991 | 1 |
| 18 | In vitro clonogenicity in relation to kinetic and clinicopathological features of breast cancer. | 1988 | 7 |
| 19 | 1988 | 60 | |
| 20 | Caryotype 46,XY-47,XXY-48,XXXY dans deux observations de syndrome de Klinefelter. | 1970 | 1 |
About M Namer
M Namer is a scholar working on Oncology, Cancer Research, Dermatology, Genetics and Hepatology, having authored 36 papers that have together received 442 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Neutropenia and Cancer Infections (4 papers), Chemotherapy-related skin toxicity (4 papers), Estrogen and related hormone effects (3 papers), Colorectal and Anal Carcinomas (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (271 citations), Cancer Research (84 citations), Genetics (50 citations), Pulmonary and Respiratory Medicine (116 citations) and Dermatology (31 citations). M Namer has collaborated with scholars based in France, Belgium and Italy. Frequent co-authors include G. Milano, Marc Frénay, N. Renée, M. Frénay, P. Román, Jean-Michel Derlon, B. Giroux, Jacques Bonneterre, Joseph Gligorov and M. Spielmann. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Breast Cancer Research and Treatment, Diseases of the Colon & Rectum and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.